Skip to main content
. Author manuscript; available in PMC: 2013 Oct 7.
Published in final edited form as: Cancer Invest. 2012 Sep 28;30(9):679–682. doi: 10.3109/07357907.2012.726386

Table 1.

Treatment flow chart

DRUG/DOSE DAY -4 DAY -3 DAY -2 DAY -1 DAY 0–4
Alemtuzumab (in vivo) 20 mg/day x x x x
Fludarabine 40 mg/m2/day x x x x
Busulfan TEST dose 13 mg/m2 (18 min infusion) x
Busulfan THERAPY dose 130 mg/m2/day (180 min infusion) x x
Allogeneic PBSC infusion x